Literature DB >> 30057404

Viruses in cancer therapy - from benchwarmers to quarterbacks.

Pierpaolo Peruzzi1, E Antonio Chiocca2.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30057404      PMCID: PMC6689225          DOI: 10.1038/s41571-018-0077-0

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  6 in total

Review 1.  Focused Ultrasound Strategies for Brain Tumor Therapy.

Authors:  Adomas Bunevicius; Nathan Judson McDannold; Alexandra J Golby
Journal:  Oper Neurosurg (Hagerstown)       Date:  2020-07-01       Impact factor: 2.703

Review 2.  Current state and future of co-inhibitory immune checkpoints for the treatment of glioblastoma.

Authors:  Shaoping Shen; Ling Chen; Jialin Liu; Lin Yang; Mengna Zhang; Lingxiong Wang; Rong Zhang; Yasushi Uemura; Qiyan Wu; Xinguang Yu; Tianyi Liu
Journal:  Cancer Biol Med       Date:  2020-08-15       Impact factor: 4.248

Review 3.  Current State of Immunotherapy for Treatment of Glioblastoma.

Authors:  Tresa McGranahan; Kate Elizabeth Therkelsen; Sarah Ahmad; Seema Nagpal
Journal:  Curr Treat Options Oncol       Date:  2019-02-21

4.  Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade.

Authors:  Sharmila Nair; Luciano Mazzoccoli; Arijita Jash; Jennifer Govero; Sachendra S Bais; Tong Hu; Camila R Fontes-Garfias; Chao Shan; Hideho Okada; Sujan Shresta; Jeremy N Rich; Pei-Yong Shi; Michael S Diamond; Milan G Chheda
Journal:  JCI Insight       Date:  2021-01-11

5.  AXL receptor is required for Zika virus strain MR-766 infection in human glioblastoma cell lines.

Authors:  Samuel D Zwernik; Beau H Adams; Daniel A Raymond; Catherine M Warner; Amin B Kassam; Richard A Rovin; Parvez Akhtar
Journal:  Mol Ther Oncolytics       Date:  2021-11-11       Impact factor: 7.200

6.  Viral oncogenesis in tumours of the central nervous system: reality or random association? A retrospective study on archived material.

Authors:  Dorel Eugen Arsene; Elena Milanesi; Maria Dobre
Journal:  J Cell Mol Med       Date:  2022-02-02       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.